AbbVie Inc - Strategy, SWOT and Corporate Finance Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $175	80 Pages	MarketLine	February, 2022	MTLN17055636

Attention: There is an updated edition available for this report.

Best Price Guarantee
Price	from $175
Length	80 Pages
Publisher	MarketLine
Published Date	February, 2022
SKU	MTLN17055636

AbbVie Inc - Strategy, SWOT and Corporate Finance Report

Summary

AbbVie Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

AbbVie Inc. (AbbVie or ‘the company’) is a biopharmaceutical company that discovers, develops, manufactures and commercializes drugs for the treatment of chronic and complex diseases. The company develops pharmaceutical products that mainly consist of Humira (adalimumab) and products in therapeutic areas of oncology, metabolic/hormones, endocrinology, and virology. The company also provides patient support programs and partners with academic institutions, biotechnology companies and other pharmaceutical companies. The company sells its products directly to distributors, wholesalers, health care facilities, specialty pharmacies, government agencies and independent retailers from the company-owned distribution centers and public warehouses. It has business presence in the US, the UK, Canada, Mexico, European Union, Japan, Brazil and other countries. The company is headquartered in North Chicago, Illinois, the US.

Scope

Detailed information on AbbVie Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting AbbVie Inc in the form of a SWOT analysis
An in-depth view of the business model of AbbVie Inc including a breakdown and examination of key business segments
Intelligence on AbbVie Inc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about AbbVie Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of AbbVie Inc and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess AbbVie Inc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on AbbVie Inc's business structure, strategy and prospects.

Company Snapshot: AbbVie Inc.: Company Overview; AbbVie Inc.: Overview and Key Facts; AbbVie Inc.: Overview; AbbVie Inc.: Key Facts; AbbVie Inc.: Key Employees; AbbVie Inc.: Key Employee Biographies; AbbVie Inc.: Major Products and Services; AbbVie Inc.: Company History; AbbVie Inc.: Management Statement; AbbVie Inc.: Locations and Subsidiaries; AbbVie Inc.: Key Competitors; AbbVie Inc.: Company Analysis; AbbVie Inc.: Business Description; AbbVie Inc.: SWOT Analysis; AbbVie Inc.: SWOT Overview; AbbVie Inc.: Strengths; AbbVie Inc.: Weaknesses; AbbVie Inc.: Opportunities; AbbVie Inc.: Threats; AbbVie Inc.: Corporate Financial Deals Activity; AbbVie Inc.: Financial Deals Overview; AbbVie Inc.: Targets and Partners; AbbVie Inc.: Top Deals 2018 - 2022YTD*; AbbVie Inc.: Advisors; AbbVie Inc.: Top Legal Advisors; AbbVie Inc.: Top Financial Advisors; AbbVie Inc.: Mergers and Acquisitions; AbbVie Inc.: Corporate Venturing; AbbVie Inc.: Capital Raising; AbbVie Inc.: Partnership; AbbVie Inc.: Divestments; AbbVie Inc.: Private Equity and Ownership; AbbVie Inc.: Recent Developments; AbbVie Inc.: News and Events Summary; AbbVie Inc.: Business Expansion; AbbVie Inc.: Contracts; AbbVie Inc.: Financial Performance; AbbVie Inc.: Regulatory and Legal Events; AbbVie Inc.: Strategy and Operations
Appendix: Contact Us; Methodology; About MarketLine
List of Tables: Table 1: AbbVie Inc.: Key Facts; Table 2: AbbVie Inc.: Key Employees; Table 3: AbbVie Inc.: Company History; Table 4: AbbVie Inc.: Locations and Subsidiaries; Table 5: AbbVie Inc.: Key Competitors; Table 6: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*); Table 7: AbbVie Inc.: M&A Activity by Geography (TTM*); Table 8: AbbVie Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022); Table 9: AbbVie Inc.: M&A Average Deal Size - Value (US$m); Table 10: AbbVie Inc.: Targets and Partners; Table 11: AbbVie Inc.: Top Deals 2018 - 2022YTD*; Table 12: AbbVie Inc.: Legal Advisor Ranking by Value (US$m); Table 13: AbbVie Inc.: Financial Advisor Ranking by Value (US$m); Table 14: AbbVie Inc.: M&A Volume and Value Trend (2018 - YTD*2022); Table 15: AbbVie Inc.: M&A Activity by Geography (2018 - YTD*2022); Table 16: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022); Table 17: AbbVie Inc.: Corporate Venturing by Geography (2018 - YTD*2022); Table 18: AbbVie Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022); Table 19: AbbVie Inc.: Capital Raising by Deal Type (2018 - YTD*2022); Table 20: AbbVie Inc.: Partnership Volume and Value Trend (2018 - YTD*2022); Table 21: AbbVie Inc.: Partnership Trend by Deal Type (2018 - YTD*2022); Table 22: AbbVie Inc.: Divestments Volume and Value Trend (2018 - YTD*2022); Table 23: AbbVie Inc.: Divestments by Geography (2018 - YTD*2022); Table 24: AbbVie Inc.: Private Equity and Ownership Volume and Value Trend (2018 - YTD*2022); Table 25: AbbVie Inc.: Private Equity and Ownership Volume by Deal Type (2018 - YTD*2022); Table 26: AbbVie Inc.: News and Events Summary; Table 27: AbbVie Inc.: Business Expansion; Table 28: AbbVie Inc.: Contracts; Table 29: AbbVie Inc.: Financial Performance; Table 30: AbbVie Inc.: Regulatory and Legal Events; Table 31: AbbVie Inc.: Strategy and Operations
List of Figures: Figure 1: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*); Figure 2: AbbVie Inc.: M&A Activity by Geography (TTM*); Figure 3: AbbVie Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022); Figure 4: AbbVie Inc.: M&A Average Deal Size - Value (US$m); Figure 5: AbbVie Inc.: M&A Volume and Value Trend (2018 - YTD*2022); Figure 6: AbbVie Inc.: M&A Activity by Geography (2018 - YTD*2022); Figure 7: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022); Figure 8: AbbVie Inc.: Corporate Venturing by Geography (2018 - YTD*2022); Figure 9: AbbVie Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022); Figure 10: AbbVie Inc.: Capital Raising by Deal Type (2018 - YTD*2022); Figure 11: AbbVie Inc.: Partnership Volume and Value Trend (2018 - YTD*2022); Figure 12: AbbVie Inc.: Partnership Trend by Deal Type (2018 - YTD*2022); Figure 13: AbbVie Inc.: Divestments Volume and Value Trend (2018 - YTD*2022); Figure 14: AbbVie Inc.: Divestments by Geography (2018 - YTD*2022); Figure 15: AbbVie Inc.: Private Equity and Ownership Volume and Value Trend (2018 - YTD*2022); Figure 16: AbbVie Inc.: Private Equity and Ownership Volume by Deal Type (2018 - YTD*2022)